EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts

Yukinobu Kawakami, Takuya Matsuda, Noriaki Hidaka, Mamoru Tanaka, Eizen Kimura

Journal of the American Medical Informatics Association · 2024

DOI: 10.1093/jamia/ocae094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Medical Informatics Association, 2024. Verfasst von Yukinobu Kawakami und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Informatics, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan. Hauptthemen laut MEDLINE: Drug Interactions, Knowledge Bases, RxNorm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Linking information on Japanese pharmaceutical products to global knowledge bases (KBs) would enhance international collaborative research and yield valuable insights. However, public access to mappings of Japanese pharmaceutical products that use international controlled vocabularies remains limited. This study mapped YJ codes to RxNorm ingredient classes, providing new insights by comparing Japanese and international drug-drug interaction (DDI) information using a case study methodology. Materials and Methods Tables linking YJ codes to RxNorm concepts were created using the application programming interfaces of the Kyoto Encyclopedia of Genes and Genomes and the National Library of Medicine. A comparative analysis of Japanese and international DDI information was thus performed by linking to an international DDI KB.

Results

There was limited agreement between the Japanese and international DDI severity classifications. Cross-tabulation of Japanese and international DDIs by severity showed that 213 combinations classified as serious DDIs by an international KB were missing from the Japanese DDI information.

Discussion

It is desirable that efforts be undertaken to standardize international criteria for DDIs to ensure consistency in the classification of their severity.

Conclusion

The classification of DDI severity remains highly variable. It is imperative to augment the repository of critical DDI information, which would revalidate the utility of fostering collaborations with global KBs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug InteractionsKnowledge BasesRxNormJapanHumansVocabulary, ControlledEast Asian People

Stichwörter der Autor:innen

RxNormdrug codesdrug-drug interactionknowledge baseterminology

Autor:innen und Institutionen

  • Department of Medical Informatics, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
  • Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, 791-0295, Japan.

Zitieren

APA

Kawakami, Y., Matsuda, T., Hidaka, N., Tanaka, M., & Kimura, E. (2024). Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocae094

Vancouver

Kawakami Y, Matsuda T, Hidaka N, Tanaka M, Kimura E. Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts. Journal of the American Medical Informatics Association. 2024. doi:10.1093/jamia/ocae094

BibTeX
@article{Kawakami2024,
  author = {Kawakami, Yukinobu and Matsuda, Takuya and Hidaka, Noriaki and Tanaka, Mamoru and Kimura, Eizen},
  title = {Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts},
  journal = {Journal of the American Medical Informatics Association},
  year = {2024},
  doi = {10.1093/jamia/ocae094}
}
Kostenlos starten →